Complete responses and long‐term survivals after systemic chemotherapy for patients with advanced malignant melanoma

Five hundred three patients with advanced malignant melanoma were exposed to a number of clinical investigative chemotherapeutic regimens between 1971 and 1984 in an effort to assess the clinical activity of these regimens in this disease. Of the 503 patients participating in the studies, ten patien...

Full description

Saved in:
Bibliographic Details
Published in:Cancer 1989-01, Vol.63 (2), p.224-227
Main Authors: Ahmann, David L., Creagan, Edward T., Hahn, Richard G., Edmonson, John H., Bisel, Harry F., Schaid, Daniel J.
Format: Article
Language:English
Subjects:
Adult
Aged
Antineoplastic agents
Antineoplastic Combined Chemotherapy Protocols - therapeutic use
Biological and medical sciences
Chemotherapy
Clinical Trials as Topic
Female
Humans
Male
Medical sciences
Melanoma - drug therapy
Melanoma - mortality
Middle Aged
Pharmacology. Drug treatments
Prognosis
Remission Induction
Skin Neoplasms - drug therapy
Skin Neoplasms - mortality
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Five hundred three patients with advanced malignant melanoma were exposed to a number of clinical investigative chemotherapeutic regimens between 1971 and 1984 in an effort to assess the clinical activity of these regimens in this disease. Of the 503 patients participating in the studies, ten patients experienced a complete response. However, only three of these patients survived more than 5 years. Of this group of 503 patients, seven additional patients who did not experience a complete response survived more than five years. Of the ten patients surviving more than 5 years, two had immediate progression after institution of investigative regimens, whereas five remained stable for brief periods of time before progressive metastatic disease. Three patients experienced a complete response. It appeared that systemic therapeutic interventions in these trials were conspicuously ineffective for this large group of patients. A few long‐term survivors attest to the capricious nature of this neoplasm and its association with likely spontaneous regressions. Although these long‐term survivors did survive after institution of systemic chemotherapy, it is likely that this survival was related temporally, but perhaps not causally, to the institution of treatment.
ISSN:0008-543X
1097-0142
DOI:10.1002/1097-0142(19890115)63:2<224::AID-CNCR2820630203>3.0.CO;2-I